42 -1 (75) 2025 - Ismailova J.A., Dalimova D.A. - ROLE OF THE GUT MICROBIOME IN THE DEVELOPMENT OF STOMACH DISEASES

ROLE OF THE GUT MICROBIOME IN THE DEVELOPMENT OF STOMACH DISEASES

Ismailova J.A. - The respulican specialized scantific practical medical of therapy and medical rehabilitation Osiyo street Toshkent

Dalimova D.A. - Center for Advanced Technologies under the Ministry of Innovative Development, Uzbekistan

Raximova Sh.Sh. - The respulican specialized scantific practical medical of therapy and medical rehabilitation Osiyo street Toshkent

Resume

The authors analyzed new information about the role of the intestinal microbiome in the development of gastric diseases. Microbiome research is one of the actively developing areas in modern medicine. H. pylori is a well-established risk factor for gastric cancer. In recent years, there has been increasing evidence that bacteria other than H. pylori and their metabolites also contribute to gastric carcinogenesis. Tadqiqotlar shuni ko'rsatadiki, oshqozon mikrobiomasining turli komponentlari oshqozon saratoni rivojlanishiga ta'sir qilishi mumkin, ammo individual patogenlarning roli aniq emas. Shuningdek, 16S rRNK ketma-ketligi yordamida mikrobioma tarkibini va uning xavfsizlik parametrlari bilan bog'liqligini, shu jumladan oshqozon saratoni rivojlanish xavfini o'rganish uchun tahlil qilish. Studying the gut microbiome in the development and progression of gastric diseases may lead to improved prevention, diagnosis and treatment

Key words: H. pylori, intestinal microbiome, gastric cancer, 16S rRNA sequencing, chronic gastritis, diagnostic biomarkers.

First page

258

Last page

263

For citation:Ismailova J.A., Dalimova D.A., Raximova Sh.Sh - ROLE OF THE GUT MICROBIOME IN THE DEVELOPMENT OF STOMACH DISEASES//New Day in Medicine 1(75)2025 258-263 https://https://newdayworldmedicine.com/en/new_day_medicine/1-75-2025

List of References

  1. Berg RD. The indigenous gastrointestinal microflora. //Trends Microbiol. 1996;4:430-5
  2. Bik EM, Eckburg PB, Gill SR, Nelson KE, Purdom EA, Francois F. et al. Molecular analysis of the bacterial microbiota in the human stomach. //Proc Natl Acad Sci U S A. 2006;103:732-7
  3. Carly Anderson The Human Microbiome. Microbiome Part 1: Introduction Prime Movers Lab, May 26, 2020 diagnostic biomarker in Chinese patients with gastric cancer: a systematic meta-analysis mSystems® October 2023;8(5) DOI:10.1128/msystems.00747-23
  4. doi: 10.1007/s00253-020-11043-7. Epub 2021 Jan 6. Gut microbiome analysis as a predictive marker for the gastric cancer patients doi: 10.1038/nrgastro.2017.140. Epub 2017 Oct 18.
  5. Fulbright LE, Ellermann M, Arthur JC (2017) The microbiome and the hallmarks of cancer. PLoS Pathog 2017;13(9):e1006480. https://doi.org/10.1371/journal.ppat.1006480
  6. Helicobacter 2019 Feb;24(1):e12547. doi: 10.1111/hel.12547. Epub 2018 Nov 15.Chan Hyuk Park, A-Reum Lee, Yu-Ra Lee, Chang Soo Eun, Sang Kil Lee, Dong Soo Han. Evaluation of gastric microbiome and metagenomic function in patients with intestinal metaplasia using 16S rRNA gene sequencing PMID: 30440093 PMCID: PMC6587566 DOI: 10.1111/hel.12547
  7. International Agency for Research on Cancer, World Health Organization. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7–14. //IARC Monogr Eval Carcinog Risks Hum. 1994;61:1–241.
  8. Jijun Chen, Siru Nie, Xunan Qiu, Shuwen Zheng, Chuxuan Ni, Yuan Yuan, Yuehua Gong Leveraging existing 16S rRNA microbial data to identify
  9. Jinpu Yang, Xinxin Zhou, Xiaosun Liu, Zongxin Ling, *Feng Ji. Role of the Gastric Microbiome in Gastric Cancer: From Carcinogenesis to Treatment Front. Microbiol., 15 March 2021 Sec. Systems Microbiology
  10. Liu X, Shao L, Liu X, Ji F, Mei Y, Cheng Y. et al. Alterations of gastric mucosal microbiota across different stomach microhabitats in a cohort of 276 patients with gastric cancer. //EBioMedicine. 2019;40:336-48
  11. Olabisi Oluwabukola Coker, Zhenwei Dai, Yongzhan Nie, Guijun Zhao, Lei Cao, Geicho Nakatsu, William Kk Wu, Sunny Hei Wong, Zigui Chen, Joseph J Y Sung, Jun Yu Gut. 2018 Jun;67(6):1024-1032.doi: 10.1136/gutjnl-2017-314281. Epub 2017 Aug Mucosal microbiome dysbiosis in gastric carcinogenesis PMID: 33404833 DOI: 10.1007/s00253-020-11043-7
  12. Png CW, Lee WJJ, Chua SJ, Zhu F, Gastric Consortium5, Yeoh KG, Zhang Y. Mucosal microbiome associates with progression to gastric cancer. //Theranostics 2022;12(1):48-58. doi:10.7150/thno.65302. https://www.thno.org/v12p0048.htm
  13. Shah MA. Gastric cancer: The gastric microbiota - bacterial diversity and implications. //Nat Rev Gastroenterol Hepatol. 2017 Dec;14(12):692-693.
  14. The Human Gastric Microbiome Is Predicated upon Infection with Helicobacter pylori Ingeborg Klymiuk, Ceren Bilgilier, Alexander Stadlmann, Jakob Thannesberger, Marie-Theres Kastner, Christoph Högenauer , Andreas Püspök, Susanne Biowski-Frotz, Christiane Schrutka-Kölb , Gerhard G. Thallinger and Christoph Steininger Front. Microbiol., 14 December 2017 Sec. Infectious Agents and Disease Volume 8 - 2017 | https://doi.org/10.3389/fmicb.2017.02508 Volume 12 - 2021 | https://doi.org/10.3389/fmicb.2021.641322
  15. Wang L, Xin Y, Zhou J, Tian Z, Liu C, Yu X. et al. Gastric Mucosa-Associated Microbial Signatures of Early Gastric Cancer. //Front Microbiol. 2020;11:1548
  16. Yangyang Zhang, Jian Shen, Xinwei Shi, Yaoqiang Du, Yaofang Niu, Gulei Jin, Zhen Wang, Jianxin LyuAppl Microbiol Biotechnol. 2021 Jan;105(2):803-814.
  17. Ying Liu, Yong-Jun Ma, Cai-Qun Huang Chin Med Sci J. 2022 Mar 31;37(1):44-51. Evaluation of the Gastric Microbiome in Patients with Chronic Superficial Gastritis and Intestinal Metaplasia doi: 10.24920/003889. PMID: 35256045
  18. Брей Ф., Ферли Дж., Соерджоматарам И., Сигел Р.Л., Торре Л.А., Джемал А. Глобальная статистика рака за 2018 год: оценки GLOBOCAN заболеваемости и смертности от 36 видов рака в 185 странах. //CA Cancer J Clin. 2018;68:394-424
  19. Жесткова Т.В., Санкин А.В., Евдокимова О.В., Журина O.Н. Особенности микробиоты желудка пациентов с Helicobacter pylori-ассоциированными заболеваниями. //Эффективная фармакотерапия. 2021;17(4):22-26.
  20. Кокер О.О., Дай З., Не Й., Чжао Г., Цао Л., Накацу Г. и др. Дисбиоз микробиома слизистой оболочки при канцерогенезе желудка. //Gut. 2018;67:1024-32

    file

    download